Johnson & JohnsonvsPediatrix Medical

JNJ and MD stock compared: price, dividend, valuation and results, from SEC filings.

MD

Pediatrix Medical Group, Inc.

$31.34

Value $2.4B

-1.71%
MD's page

Johnson & Johnson (JNJ) has a market value of $672B and Pediatrix Medical (MD) $2.4B. Over the last year, with dividends, JNJ moved +45.6% and MD +35.4%. The P/E is 41.8 for JNJ and 16.3 for MD. Dividend yield: JNJ 1.89%, MD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$672B

    MD$2.4B

    JNJ is 275 times MD

  • Revenue, 12 months

    JNJ$99.3B

    MD$2.0B

    JNJ is 51 times MD

  • Net income, 12 months

    JNJ$16.1B

    MD$150M

    JNJ is 107 times MD

  • Operating margin

    JNJ–

    MD10.9%

  • ROIC

    JNJ12.4%

    MD10.7%

    1.7 points apart

  • P/E

    JNJ41.8

    MD16.3

    JNJ is 2.6 times MD

  • Dividend yield

    JNJ1.9%

    MD0.0%

    1.9 points apart

  • 5-year return

    JNJ+97.1%

    MD+16.5%

    80.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+97.1%

MD+16.6%

5010015020020222023202420252026
Returns by period
PeriodJNJWith dividendsMDWith dividends
1 year since November 14, 2025+45.6%Price +42.4%+35.4%Price +35.4%
3 years since November 17, 2023+102.8%+26.6% a yearPrice +86.2%+244.4%+51.0% a yearPrice +244.4%
5 years since November 16, 2021+97.1%+14.5% a yearPrice +71.5%+16.5%+3.1% a yearPrice +16.5%
10 years since November 17, 2016+214.0%+12.1% a yearPrice +139.3%-51.3%-6.9% a yearPrice -51.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonMDPediatrix Medical

Valuation

JNJMD
Valuation
Price$278.95$31.34
Market value$672B$2.4B
Enterprise value (EV)$700B$2.6B
P/E41.816.3
P/E, 5-year median21.915.3
P/B8.32.9
EV/EBIT39.512.2
Free cash flow yield3.1%8.6%

Results and growth

JNJMD
Results and growth
Revenue, 12 months$99.3B$2.0B
Net income, 12 months$16.1B$150M
Free cash flow, 12 months$20.6B$210M
Earnings per share, 12 months$6.59$1.84
Revenue growth, year on year6.1%-4.9%
Revenue growth a year, past+2.7%over 5 years+2.0%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJMD
Margins and returns on capital
Gross margin67.6%–
Operating margin–10.9%
Net margin16.2%7.7%
ROIC12.4%10.7%
ROE19.7%17.2%

Balance sheet

JNJMD
Balance sheet
Cash$17.2B$426M
Total debt$44.7B$612M
Net debt / EBITDA1.10.7
Interest cover18.0×6.4×

Dividends and buybacks

JNJMD
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%3.5%
Shareholder yield2.8%3.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or MD

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Pediatrix Medical?

By market value, Johnson & Johnson ($672B) is about 274.5 times Pediatrix Medical ($2.4B), at today's prices.

How did JNJ and MD stock do over the last 10 years?

Since November 17, 2016, JNJ's price moved +139.3% and MD's -51.3%. With dividends: JNJ +214.0% (+12.1% a year), MD -51.3% (-6.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or MD?

The dividend yield at today's price is 1.89% for Johnson & Johnson and none for Pediatrix Medical. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and MD?

At today's price, the P/E is 41.8 for JNJ and 16.3 for MD. The median of the last five years was 21.9 and 15.3, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Pediatrix Medical?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 7.7% for Pediatrix Medical, and the operating margin – and 10.9%. Revenue was $99.3B and $2.0B.

Which is the better investment, Johnson & Johnson or Pediatrix Medical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.